网侦系统 NTCT 深 沪
已收盘 02-06 16:00:00 美东时间
27.67
+0.600
+2.22%
华盛通- 最 高27.845
- 今 开27.47
- 成交量 68.82万股
- 最 低 27.19
- 昨 收 27.07
- 总市值 19.98亿
- 52周最高 30.6706
- 市盈率 静 --
- 换手率 0.95%
- 52周最低 18.12
- 委 比 -17.22%
- 总股本 7219.37万
- 历史最高 48.13
- 量 比 1.26
- 振 幅 2.42%
- 历史最低 10.68
- 每 手 1
- 风险率 2.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NetScout Systems Raises FY2026 GAAP EPS Guidance from $1.13-$1.23 to $1.15-$1.23 vs $1.17 Est
NetScout Systems (NASDAQ:NTCT) raises FY2026 GAAP EPS guidance from $1.13-$1.23 to $1.15-$1.23 vs $1.17 analyst estimate..
02-05 20:37
NetScout Systems Q3 Adj. EPS $1.00 Beats $0.83 Estimate, Sales $250.700M Beat $233.522M Estimate
NetScout Systems (NASDAQ:NTCT) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.83 by 20.92 percent. This is a 6.38 percent increase over earnings of $0.94 per share from the
02-05 20:34
NetScout Q3 FY26 revenue at USD 250.7 million
NetScout Q3 FY26 revenue at USD 250.7 million NetScout Systems Inc. reported financial results for the third quarter (Q3) of fiscal year 2026, with total revenue of USD 250.7 million for the period ended December 31, 2025. The company stated that its quarterly results exceeded both top and bottom-li
02-05 20:32
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
RBC Capital Maintains Sector Perform on NetScout Systems, Lowers Price Target to $29
RBC Capital analyst Matthew Hedberg maintains NetScout Systems (NASDAQ:NTCT) with a Sector Perform and lowers the price target from $31 to $29.
01-06 00:15
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
NetScout Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
NetScout Systems shares are trading higher after the company reported better-th...
2025-11-06 22:03
NetScout Systems Raises FY2026 Adj EPS Guidance from $2.25-$2.40 to $2.35-$2.45 vs $2.33 Est; Raises FY2026 Sales Guidance from $825.000M-$865.000M to $830.000M-$870.000M vs $849.262M Est
NetScout Systems (NASDAQ:NTCT) raises FY2026 Adj EPS guidance from $2.25-$2.40 to $2.35-$2.45 vs $2.33 analyst estimate. Raises FY2026 sales outlook from $825.000 million-$865.000 million to $830.000 million-$870.000
2025-11-06 20:31
Netscout Systems Approves Equity Plan Amendment
An announcement from Netscout Systems ( ($NTCT) ) is now available. On Septembe...
2025-09-13 05:21
